Application and progress of PET radionuclides in brain glioma

Brain glioma is one of the most common diseases that threatens people's health. Recently, various novel PET radionuclides have been invented and introduced into clinical practice. They have shown potentials in wide fields, such as diagnosis, tumor grading, preoperative evaluation, therapeutic efficacy, etc. We reviewed several types of PET radionuclides that used for brain glioma imaging, such as fluorescent glucose analog, radiolabled amino acid, and anloges of nucleoside, hypoxia, and choline. (authors)